Imigran 10 mg Nasal Spray, Solution Írland - enska - HPRA (Health Products Regulatory Authority)

imigran 10 mg nasal spray, solution

glaxosmithkline (ireland) limited - sumatriptan - nasal spray, solution - 10 milligram(s) - selective serotonin (5ht1) agonists; sumatriptan

IPV Infanrix suspension for injection in pre-filled syringe Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed) Írland - enska - HPRA (Health Products Regulatory Authority)

ipv infanrix suspension for injection in pre-filled syringe diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)

glaxosmithkline (ireland) limited - pertussis toxoid; filamentous haemagglutinin; pertactin; diphtheria toxoid; tetanus toxoid; polio virus type 1 inactivated; polio virus type 2 inactivated; polio virus type 3 inactivated - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - diphtheria-pertussis-poliomyelitis-tetanus

Zantac 25 mg/ml Solution for Injection/Infusion Írland - enska - HPRA (Health Products Regulatory Authority)

zantac 25 mg/ml solution for injection/infusion

glaxosmithkline (ireland) limited - ranitidine - solution for injection/infusion - 25 milligram(s)/millilitre - h2-receptor antagonists; ranitidine

Betnovate RD (Ready Diluted) 0.025% w/w Cream Írland - enska - HPRA (Health Products Regulatory Authority)

betnovate rd (ready diluted) 0.025% w/w cream

glaxosmithkline (ireland) limited - betamethasone valerate - cream - 0.025 percent weight/weight - corticosteroids, potent (group iii); betamethasone

Betnovate RD (Ready Diluted) 0.025% w/w Ointment Írland - enska - HPRA (Health Products Regulatory Authority)

betnovate rd (ready diluted) 0.025% w/w ointment

glaxosmithkline (ireland) limited - betamethasone valerate - ointment - 0.025 percent weight/weight - corticosteroids, potent (group iii); betamethasone

Betnovate Scalp Application 0.1% w/v Cutaneous Solution Írland - enska - HPRA (Health Products Regulatory Authority)

betnovate scalp application 0.1% w/v cutaneous solution

glaxosmithkline (ireland) limited - betamethasone - cutaneous solution - 0.1 percent weight/volume - corticosteroids, potent (group iii); betamethasone

Engerix B 20 micrograms/1 ml Suspension for injection in pre-filled syringe Hepatitis B (rDNA) vaccine (adsorbed) (HBV) Írland - enska - HPRA (Health Products Regulatory Authority)

engerix b 20 micrograms/1 ml suspension for injection in pre-filled syringe hepatitis b (rdna) vaccine (adsorbed) (hbv)

glaxosmithkline (ireland) limited - hepatitis b surface antigen, recominant - suspension for injection in pre-filled syringe - 20/1 microgram(s)/millilitre - hepatitis vaccines; hepatitis b, purified antigen

TYPHERIX 50.0 Microgram/ML Solution for injection in pre-filled syringe Írland - enska - HPRA (Health Products Regulatory Authority)

typherix 50.0 microgram/ml solution for injection in pre-filled syringe

glaxosmithkline (ireland) limited - salmonella typhi, vi antigen - solution for injection in pre-filled syringe - 50.0 microgram/ml - typhoid vaccines

Amoxil Paediatric 125 mg/1.25 ml Powder for Oral Suspension Írland - enska - HPRA (Health Products Regulatory Authority)

amoxil paediatric 125 mg/1.25 ml powder for oral suspension

glaxosmithkline (ireland) limited - amoxicillin - powder for oral suspension - 125 mg/1.25 millilitre(s) - penicillins with extended spectrum; amoxicillin

Dermovate Scalp Application 0.05% w/v Cutaneous Solution Írland - enska - HPRA (Health Products Regulatory Authority)

dermovate scalp application 0.05% w/v cutaneous solution

glaxosmithkline (ireland) limited - clobetasol propionate - cutaneous solution - 0.05 percent weight/volume - corticosteroids, very potent (group iv); clobetasol